Life Sciences Companies Insurance

IMI Insurance stands for Insurance for Medical Institutions or Insurance for Medical Innovation, and refers to a tailored group of insurance products designed to protect companies and organizations operating in the healthcare, biotech, and medical technology sectors. This includes hospitals, clinics, laboratories, clinical trial sponsors, and medical device manufacturers.

Medical research laboratories are often at the forefront of innovation, working with sensitive technologies and engaging in collaborations with hospitals, academic institutions, and pharmaceutical companies. From pre-clinical experiments and in-vitro testing to genetic data analysis and advanced medical trials — the operational and professional risks faced by labs are high and require specialized insurance coverage.

The role of investment managers is pivotal in today’s financial landscape. With significant growth in Israeli investments globally—approximately $16.5 billion in real estate alone between 2017 and 2022—managing client portfolios effectively is more critical than ever. However, the dual responsibility of maximizing client returns while adhering to stringent regulatory requirements exposes investment managers to significant risks.

The research and development (R&D) sector is at the forefront of innovation, driving technological and scientific progress across industries. However, the nature of R&D work involves significant risks, from intellectual property disputes to liabilities stemming from testing or prototype failures. Comprehensive insurance solutions are essential for safeguarding your operations and enabling your business to thrive in a competitive landscape.

Food supplement companies are engaged in the production of food supplements/marketing of food supplements for institutional and private customers.

Our insurance program for food supplement companies is adapted to all company stages, from R&D to sales. Alternatively, there is a dedicated insurance plan for distributors only. The insurance plans have global coverage and provide spatial protection for the company in each phase. Our insurance specifications are individually tailored to each and every company, taking full account of investor and customer requirements.

Research and development companies dealing in various fields, such as drug development, medical device development, consultants, and CROs, are exposed to lawsuits for financial damages

Mergers and acquisitions (M&A) insurance is insurance designed to help protect companies and their shareholders against losses that may occur during the merger and acquisition

Unfortunately, theft, embezzlement, and fraud committed against a company, business, or organization are not that rare. In recent years, we have seen and heard about

Insurance for Software Companies In recent years, the software development industry has been in an unprecedented boom and growing trend, with many companies and businesses

Since 2020, the biotechnology industry has experienced unprecedented growth, driven by innovations such as the revolutionary COVID-19 vaccine. This surge has highlighted the importance of supporting the development of medical and therapeutic products. However, this innovation comes with significant risks for pharmaceutical companies, including liabilities from clinical trials, product defects, and supply chain disruptions. Tailored insurance solutions are essential for protecting your business, employees, and innovations against the unique challenges of this critical sector.

  The world of medicine has changed significantly in recent decades. In addition to the coronavirus that accelerated significant technological developments in the field, the

In the last decade, we have heard about more and more countries and organizations joining initiatives to reduce air pollution and the environment. Among other